Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00274716
Status:
COMPLETED
Last Update Posted:
2015-07-03
First Post:
2006-01-10
Brief Title:
Safety and Efficacy of MK0736 MK0916 in Patients With Hypertension High Blood Pressure0736-003COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Placebo-Controlled Study to Assess the Efficacy and Safety of MK0736 and MK0916 in Hypertensive Patients
Status:
COMPLETED
Status Verified Date:
2015-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to evaluate the safety and efficacy of two investigational drugs MK-0736 and MK-0916 in lowering blood pressure and body weight in patients with hypertension high blood pressure
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time Full information is available to trial participants
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time Full information is available to trial participants
Detailed Description:
Participants enrolled in the study will be separated into 2 strata based on baseline body mass index BMI assessments prior to being randomly assigned to study treatment Study will include a 24-week treatment period comprised of 2 phases A and B each of which will 12 weeks in duration
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006_004 | None | None | None |